(Q40113445)

17 September 2017

1 reference

title

The use of cholinergic precursors in neuropsychiatric diseases (English)

1 reference

17 September 2017

G. S. Rosenberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6214943

30 August 2023

K. L. Davis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6214943

30 August 2023

language of work or name

English

0 references

publication date

1 October 1982

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:S0002916523158461?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

https://api.elsevier.com/content/article/PII:S0002916523158461?httpAccept=text/plain

30 August 2023

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

http://academic.oup.com/ajcn/article-pdf/36/4/709/24159756/709.pdf

30 August 2023

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

American Journal of Clinical Nutrition

30 August 2023

published in

1 reference

17 September 2017

36

1 reference

17 September 2017

709-720

1 reference

17 September 2017

4

1 reference

Choline ester formation in, and choline esterase activities of, tissues in vitro

17 September 2017

1

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Acetylcholine synthesis in a sympathetic ganglion

30 August 2023

2

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Increase in tissue concentration of acetylcholine in guinea pigs in vivo induced by administration of choline

30 August 2023

8

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Steady-state concentrations of choline and acetylcholine in rat brain parts during a constant rate infusion of deuterated choline

30 August 2023

9

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Brain acetylcholine: Increase after systematic choline administration

30 August 2023

11

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Increase in rat brain acetylcholine induced by choline or deanol

30 August 2023

12

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Regulation of acetylcholine synthesis in nervous tissue

30 August 2023

13

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

In Vivo Turnover Rate of Acetylcholine in Rat Brain Parts at Elevated Steady-State Concentration of Plasma Choline

30 August 2023

14

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Increase in hippocampal acetylcholine after choline administration

30 August 2023

16

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Choline administration: modification of the central actions of atropine.

30 August 2023

18

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

The effect of neuroleptics on acetylcholine concentration and choline uptake in striatum: Implications for regulation of acetylcholine metabolism

30 August 2023

20

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Relationship between choline availability and acetylcholine synthesis in discrete regions of rat brain

30 August 2023

21

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Tissue levels of acetyl choline and acetylcholinesterase in weanling rats subjected to acute choline deficiency

30 August 2023

23

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Choline and acetylcholine in rats: effect of dietary choline

30 August 2023

24

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Brain Acetylcholine: Control by Dietary Choline

30 August 2023

26

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Choline administration to the rat increases urinary catecholamines

30 August 2023

28

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Choline Administration: Activation of Tyrosine Hydroxylase in Dopaminergic Neurons of Rat Brain

30 August 2023

29

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Homovanillic acid concentration in rat brain: Effect of a choline acetyltransferase inhibitor and comparison with cholinergic and dopaminergic agents

30 August 2023

30

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Nature and mechanisms of cholinergic-monoaminergic interactions in the brain

30 August 2023

31

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Choline administration: Central effect mediated by stimulation off acetylcholine synthesis

30 August 2023

32

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Choline acetyltransferase inhibitors: a group of styryl-pyridine analogs.

30 August 2023

33

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Choline Excites Cortical Neurons

30 August 2023

34

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Cholinergic inhibition of methylphenidate-induced stereotypy: Oxotremorine

30 August 2023

35

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Cholinergic antagonism of methylphenidate-induced stereotyped behavior

30 August 2023

36

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Cholinergic and anticholinergic influences on amphetamine-induced stereotyped behavior

30 August 2023

37

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Choline chloride in methylphenidate- and apomorphine-induced stereotypy

30 August 2023

38

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Brain cholinergic dysfunction and memory in aged rats

30 August 2023

39

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

30 August 2023

40

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Choline-induced attenuation of morphine analgesia in the rat

30 August 2023

41

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Potentiation of a non-narcotic analgesic, dipyrone, by cholinomimetic drugs

30 August 2023

42

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Studies on the central antinociceptive action of cholinomimetic agents

30 August 2023

43

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Determination and characterization of the antinociceptive activity of intraventricularly administered acetylcholine in mice

30 August 2023

44

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Central cholinergic-anticholinergic antagonism in Huntington's chorea

30 August 2023

46

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Effect of cholinergic and anticholinergic agents on tardive dyskinesia

30 August 2023

47

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Physostigmine in rigid Huntington's disease.

30 August 2023

48

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Choline in tardive dyskinesia and Huntington's disease

30 August 2023

49

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

A pharmacologic analysis of Huntington's chorea

30 August 2023

51

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Persistence of Neurological Symptoms Due to Neuroleptic Drugs

30 August 2023

52

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Observations on the effect of levodopa on tardive lingual-facial-buccal dyskinesia

30 August 2023

53

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Cerebrospinal fluid choline in extrapyramidal disorders

30 August 2023

54

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Choline acetylase and glutamic acid decarboxylase in Huntington's chorea. A preliminary study

30 August 2023

55

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Cholinergic and dopaminergic mechanisms in Huntington's chorea

30 August 2023

56

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Letter: Choline for tardive dyskinesia

30 August 2023

58

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Cholinergic influences in tardive dyskinesia

30 August 2023

60

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Oral choline administration to patients with tardive dyskinesia

30 August 2023

61

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Plasma concentrations of choline in man following choline chloride

30 August 2023

63

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Huntington's disease: Clinical and chemical effects of choline administration

30 August 2023

64

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Caution on plasmapheresis for myasthenia gravis

30 August 2023

66

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study

30 August 2023

67

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Lecithin consumption raises serum-free-choline levels

30 August 2023

68

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Treatment of tardive dyskinesia with lecithin

30 August 2023

70

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Lecithin in the treatment of tardive dyskinesia

30 August 2023

71

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Choline therapy in Huntington chorea

30 August 2023

72

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Physostigmine in familial ataxias

30 August 2023

74

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Oral choline in cerebellar ataxia

30 August 2023

75

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Oral choline in cerebellar ataxia.

30 August 2023

76

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Choline in hereditary ataxia

30 August 2023

77

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

The use of choline chloride in ataxic disorders

30 August 2023

78

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Oral choline in cerebellar ataxia

30 August 2023

79

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Physostigmine in Gilles de la Tourette's syndrome

30 August 2023

81

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Cholinergic treatment in the Tourette syndrome

30 August 2023

84

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Cholinergic treatment in the Tourette syndrome

30 August 2023

85

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

A cholinergic-adrenergic hypothesis of mania and depression

30 August 2023

86

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

A dopaminergic-cholinergic mechanism in production of psychotic symptoms

30 August 2023

87

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Behavioral effects of l-Dopa in schizophrenic patients

30 August 2023

88

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Dopamine and the pharmacology of schizophrenia: the state of the evidence.

30 August 2023

89

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

The inhibition of the conditioned response and the counteraction of schizophrenia by muscarinic stimulation of the brain.

30 August 2023

90

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

The effects of physostigmine in phenothiazine resistant chronic schizophrenic patients: preliminary observations.

30 August 2023

92

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Choline chloride in schizophrenia

30 August 2023

93

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

The effects of diisopropylfluorophosphonate in schizophrenia and manic depressive psychosis

30 August 2023

94

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

SOME BEHAVIORAL CHANGES IN MAN FOLLOWING ANTICHOLINESTERASE ADMINISTRATION

30 August 2023

95

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Depressive effects of physostigmine

30 August 2023

96

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Physostigmine: effects on cognition and affect in normal subjects

30 August 2023

98

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Lecithin in mania: a preliminary report

30 August 2023

99

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies

30 August 2023

101

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Selective loss of central cholinergic neurons in Alzheimer's disease

30 August 2023

102

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Necropsy evidence of central cholinergic deficits in senile dementia

30 August 2023

103

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Neocortical cholinergic neurons in elderly people

30 August 2023

104

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Pre- and postsynaptic neurochemical alterations in Alzheimer's disease

30 August 2023

105

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Acetylcholine and choline levels in post-mortem human brain tissue: preliminary observations in Alzheimer's disease.

30 August 2023

107

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue

30 August 2023

108

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Neurotransmitter-related enzymes in senile dementia of the alzheimer type

30 August 2023

109

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

30 August 2023

110

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer's disease.

30 August 2023

111

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Human memory and the cholinergic system. A relationship to aging?

30 August 2023

112

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Physostigmine: Improvement of Long-Term Memory Processes in Normal Humans

30 August 2023

113

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Human Serial Learning: Enhancement with Arecholine and Choline Impairment with Scopolamine

30 August 2023

114

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Cholinomimetics and memory. The effect of choline chloride.

30 August 2023

116

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Choline chloride effects on memory: correlation with the effects of physostigmine.

30 August 2023

117

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Partial reversal of anticholinergic amnesia by choline chloride.

30 August 2023

118

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Choline therapy in Alzheimer's disease.

30 August 2023

120

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Choline in Alzheimer's Disease

30 August 2023

121

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Clinical effects of choline in Alzheimer senile dementia

30 August 2023

123

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Clinical effects of choline in Alzheimer's disease

30 August 2023

124

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Influence of choline on amnesia in early Alzheimer's disease

30 August 2023

125

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Lecithin in Alzheimer's disease

30 August 2023

127

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Effects of physostigmine and lecithin on memory in Alzheimer disease

30 August 2023

128

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Choline chloride effects on memory in the elderly☆

30 August 2023

130

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Choline chloride treatment of memory deficits in the elderly

30 August 2023

131

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Long-term choline treatment of memory-impaired elderly patients

30 August 2023

132

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

The spontaneous and evoked release of acetylcholine from the cerebral cortex.

30 August 2023

134

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Neuropharmacological consequences of choline administration

30 August 2023

135

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Piracetam diminishes hippocampal acetylcholine levels in rats

30 August 2023

136

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Profound effects of combining choline and piracetam on memory enhancement and cholinergic function in aged rats

30 August 2023

137

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

Physostigmine and arecoline: effects of intravenous infusions in Alzheimer presenile dementia

30 August 2023

139

1 reference

https://api.crossref.org/works/10.1093/AJCN/36.4.709

30 August 2023

Identifiers

0 references

1 reference